These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11505042)

  • 1. The role of biomarkers in alcoholism medication trials.
    Allen JP; Litten RZ; Strid N; Sillanaukee P
    Alcohol Clin Exp Res; 2001 Aug; 25(8):1119-25. PubMed ID: 11505042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations on use of biomarkers in alcoholism treatment trials.
    Allen JP; Litten RZ
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1667-70. PubMed ID: 14574239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOVER and QUVER-new marker combinations to detect and monitor at-risk drinking.
    Berner MM; Bentele M; Kriston L; Mänz C; Clement HW; Härter M; Mundle G
    Alcohol Clin Exp Res; 2006 Aug; 30(8):1372-80. PubMed ID: 16899040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients.
    Rinck D; Frieling H; Freitag A; Hillemacher T; Bayerlein K; Kornhuber J; Bleich S
    Drug Alcohol Depend; 2007 Jun; 89(1):60-5. PubMed ID: 17234365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening trauma patients with the alcohol use disorders identification test and biomarkers of alcohol use.
    Neumann T; Gentilello LM; Neuner B; Weiss-Gerlach E; Schürmann H; Schröder T; Müller C; Haas NP; Spies CD
    Alcohol Clin Exp Res; 2009 Jun; 33(6):970-6. PubMed ID: 19302090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of carbohydrate-deficient transferrin (%disialotransferrin) measured by HPLC: sensitivity, specificity, gender effects, and relationship with other alcohol biomarkers.
    Bergström JP; Helander A
    Alcohol Alcohol; 2008; 43(4):436-41. PubMed ID: 18411243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical alcohol screening in primary health care.
    Miller PM; Anton RF
    Addict Behav; 2004 Sep; 29(7):1427-37. PubMed ID: 15345274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study.
    Anton RF; Lieber C; Tabakoff B;
    Alcohol Clin Exp Res; 2002 Aug; 26(8):1215-22. PubMed ID: 12198396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment.
    Baros AM; Wright TM; Latham PK; Miller PM; Anton RF
    Alcohol Alcohol; 2008; 43(2):192-7. PubMed ID: 18039674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bayesian Alcoholism Test had better diagnostic properties for confirming diagnosis of hazardous and harmful alcohol use.
    Korzec A; de Bruijn C; van Lambalgen M
    J Clin Epidemiol; 2005 Oct; 58(10):1024-32. PubMed ID: 16168348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
    Conigrave KM; Degenhardt LJ; Whitfield JB; Saunders JB; Helander A; Tabakoff B;
    Alcohol Clin Exp Res; 2002 Mar; 26(3):332-9. PubMed ID: 11923585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between alcohol consumption and biomarkers of alcohol exposure with total serum immunoglobulin E levels.
    Friedrich N; Husemoen LL; Petersmann A; Nauck M; Völzke H; Linneberg A
    Alcohol Clin Exp Res; 2008 Jun; 32(6):983-90. PubMed ID: 18445104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of biomarkers for alcoholism by two-dimensional differential gel electrophoresis.
    Wu D; Tomonaga T; Sogawa K; Satoh M; Sunaga M; Nezu M; Oh-Ishi M; Kodera Y; Maeda T; Ochiai T; Nomura F
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S67-71. PubMed ID: 17331169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of a new assay for carbohydrate-deficient transferrin (Biorad %CDT TIA) to monitor abstinence during a treatment outcome study.
    Myrick H; Henderson S; Anton RF
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1330-4. PubMed ID: 11584153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [B-PEth and other markers of excessive alcohol us. A comparative study in general practice].
    Bjerre B
    Lakartidningen; 2009 Apr 7-21; 106(15-16):1099-100, 1102-3. PubMed ID: 19492677
    [No Abstract]   [Full Text] [Related]  

  • 19. Self-report of drinking compared to objective markers of alcohol consumption.
    Whitford JL; Widner SC; Mellick D; Elkins RL
    Am J Drug Alcohol Abuse; 2009; 35(2):55-8. PubMed ID: 19322728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comments on the article by Dastych M. et al: "Diagnostic value of carbohydrate-deficient transferrin, gamma-glutamyltransferase and mean erythrocyte volume as laboratory markers of chronic alcohol abuse"].
    Fingerová H
    Vnitr Lek; 2003 Feb; 49(2):92-4. PubMed ID: 12728573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.